THE LANGUAGE OF STIGMATIZATION AND THE MARK OF VIOLENCE: EXPERIMENTAL EVIDENCE ON THE SOCIAL CONSTRUCTION AND USE OF CRIMINAL RECORD STIGMA

After years of stagnation, labeling theory has recently gained new empirical support. Simultaneously, new policy initiatives have attempted to restructure criminal record stigma to reduce reintegration barriers, and subsequent recidivism, driven by labeling. For example, in a recent Department of Justice (DOJ) language policy, person‐first terms (e.g., “person with a conviction”) were substituted for crime‐first terms (e.g., “offender”). The Equal Employment Opportunity Commission has also issued guidelines to structure how decision‐makers use criminal records. Unfortunately, little is currently known about the social construction and use of criminal record stigma or the potential effects of such policy changes. In the current study, we provide two unique empirical tests. In study 1, we examine the social construction of stigma by testing DOJ's language policy with experimental data from a nationally representative sample of American adults (N = 996). In study 2, we use a separate nationwide experiment (N = 1,540) to examine how the contextualization of criminal records influences social exclusion decisions. Across both studies, we find consistent evidence of a “mark of violence.” The public perceives that individuals with violent convictions are the most likely to commit future crimes, and it is more supportive of excluding these individuals from employment. Crime‐first terms exacerbate perceived recidivism risk for individuals with violent convictions.     

8个miniSTR基因座复合扩增系统的建立及其应用

目的建立扩增片段〈200bp,包含CSF1PO,TH01,TPOX,D3S1358,FGA,D7S820,D21S11,PentaD 8个miniSTR基因座的复合扩增体系。方法采用四色荧光染料标记引物,PCR扩增后,应用ABI 3130遗传分析仪进行片段长度分析,对280例无关个体,137例疑难生物物证进行了检验。结果280例无关个体的调查结果为除1例在CSF1PO基因座外,其余样本的各基因座分型结果与AmpFLSTR Identifiler试剂盒完全相同。与应用ID试剂盒比较,明显提高了137例疑难生物物证的检出率。结论该检测技术方法稳定,结果准确,重复性好,且其判型结果可进行DNA数据库查询、比对,为刑事案件及灾难事故中疑难生物物证的检验提供了一条新的途径。     

Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls. Final rule

The Food and Drug Administration (FDA) is amending the packaging and labeling control provisions of the current good manufacturing practice (CGMP) regulations for human and veterinary drug products by limiting the application of special control procedures for the use of cut labeling to immediate container labels, individual unit cartons, or multiunit cartons containing immediate containers that are not packaged in individual unit cartons. FDA is also permitting the use of any automated technique, including differentiation by labeling size and shape, that physically prevents incorrect labeling from being processed by labeling and packaging equipment when cut labeling is used. This action is intended to protect consumers from labeling errors more likely to cause adverse health consequences, while eliminating the regulatory burden of applying the rule to labeling unlikely to reach or adversely affect consumers. This action is also intended to permit manufacturers to use a broader range of error prevention and labeling control techniques than permitted by current CGMPs.     

Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls--FDA. Final rule

The Food and Drug Administration (FDA) is amending the current good manufacturing practice (CGMP) regulations for human and veterinary drug products to revise certain labeling control provisions. Specifically, the final rule defines the term "gang-printed labeling," specifies conditions for the use of gang-printed or cut labeling, exempts manufacturers that employ automated 100-percent labeling inspection systems from CGMP labeling reconciliation requirements, and requires manufacturers to identify filled drug product containers that are set aside and held in an unlabeled condition for future labeling operations. These changes are intended to reduce the frequency of drug product mislabeling and associated drug product recalls.     

转基因食品标签的消费者知情权比较研究

各国对转基因食品实施了不同的标签制度:强制标签与自愿标签。这两种标签制度分别建立在消费者需要知情和消费者有权知情的法理基础之上。需要知情是以产品为基础,确保消费者对客观真实的风险知情;而有权知情往往以生产过程和生产方法为基础,以风险预防为原则管理风险以减少消费者的感知风险。一个国家采取何种转基因食品标签制度,受到该国经济、文化和政治方面的影响。我国转基因食品标签立法在即,需要借鉴其他国家的立法经验,因地制宜地实施强制标签制度,以保障消费者知情权的实现。     

The Labeling perspective and delinquency: An elaboration of the theory and an assessment of the evidence

The labeling theory of deviance was extremely popular during the 1960s and 1970s. After a series of influential critiques, however, the validity of the theory had fallen into question by 1980 and was pronounced dead by 1985. In this paper we examine the application of the labeling perspective to one particular area, juvenile delinquency. We discuss the general theoretical origin of labeling theory in both conflict theory and symbolic interactionism, and use it to present two main labeling hypotheses: 1) that status attributes are influential in determining who is labeled (the “status characteristics hypothesis”) and 2) that labeling experiences are instrumental in producing problems of adjustment and in causing subsequent commitment to further deviance (the “secondary deviance hypothesis”). We note that what is often passed off as a critique of labeling theory itself is frequently a caricature of the theory. The major point of the paper is an elaboration of the full complexity of each labeling hypothesis, a suggestion for empirical research to test it, and a review of the extant literature. We suggest that labeling theory is not as invalid as its critics have claimed, and that what is needed is a restatement and revitalization of a labeling theory of delinquency.     

Traumatic asphyxia in weightlifters

The cases presented here are an unrecognized source of accidental asphyxia--compression of the neck by barbells. Two cases of traumatic asphyxia due to this preventable hazard occurred in a 5-year period in central New York. There have been at least 11 similar deaths reported to the United States Consumer Product Safety Commission (CPSC) and cataloged in the National Electronic Injury Surveillance System between 1999 and 2002. A petition filed in 2003 with the CPSC-proposed mandatory labeling of bench presses to make consumers aware of this hazard, but was denied. This report looks at the deaths that have occurred due to this unrecognized safety threat and provides pertinent advice to make bench-pressing a safer activity.     

Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule

The Food and Drug Administration (FDA) is amending its regulations governing the format in which certain labeling is required to be submitted for review with new drug applications (NDAs), certain biological license applications (BLAs), abbreviated new drug applications (ANDAs), supplements, and annual reports. The final rule requires that certain labeling content be submitted electronically in a form that FDA can process, review, and archive. Submitting the content of labeling in electronic format will simplify the drug labeling review process and speed up the approval of labeling changes.     

How Media Exposure Relates to Laypersons’ Understanding of Psychopathy

While conceptualization of psychopathy has evolved, so too has the public's relationship with psychology changed. Concurrently, portrayal of psychopaths has made several shifts, both through nonfiction sources and in popular film and television. Psychopathic villains of the mid‐20th century have made space for a growing cast of protagonist psychopaths. This study examined whether a relationship existed between exposure to fictional psychopaths and how lay individuals conceptualize psychopathy. Specifically, this study explored conceptualization differences based on exposure to antagonist versus protagonist fictional psychopaths. Surveyed community participants supported earlier research suggesting mixed misunderstanding of psychopathy. Additionally, higher exposure to protagonist psychopaths was associated with higher endorsement of flattering distractor traits, reflecting a kind of romanticized psychopathy. These findings have legal, practical, and ethical implications, including the potential for biased jurors, confounded research about psychopathy's labeling effect, and questions about how psychologists should respond on an individual and systemic level.     

Over-the-counter human drugs; labeling requirements; final rule; technical amendment. Food and Drug Administration, HHS. Final rule; technical amendment

The Food and Drug Administration (FDA) is amending the regulation that established a standardized format and standardized content requirements for the labeling of over-the-counter (OTC) drug products, and is amending several related OTC drug product labeling regulations. This amendment corrects and conforms several aspects of the new labeling requirements to other regulatory provisions and eliminates unnecessary text from the new labeling regulation.     

OVERCOMING THE CRISIS IN CRITICAL CRIMINOLOGY: TOWARD A GROUNDED LABELING THEORY*

It has been said that critical criminology is in a state of crisis The author contends that the theoretical roots of this crisis lie in the failure of critical criminology to come to terms with the interactionist tradition from within which it developed. He shows how the traditional critical-Marxist critiques of interactionism have failed to comprehend the substance of this approach. Such substance is rooted in the social philosophy of pragmatism, especially in the thought of Mead, and in the reality of 20th-century social relationships The author proposes that the renewed critical criminology should be based in a grounded labeling theory which is able to foster consideration of both practical and discursive forms of interaction.     

Pygmalion in the reintegration process: Desistance from crime through the looking glass

The study of desistance from crime has come of age in recent years, and there are now several, competing theories to account for the ability of long-term offenders to abstain from criminal behavior. Most prominently, recent explanations have borrowed elements from informal social control theory, differential association theory and cognitive psychology. In the following, we argue that labeling theory may be a neglected factor in understanding the desistance process. Drawing on interview data collected as part of a study of an offender reintegration program, we illustrate how the idea of the “looking-glass self-concept” and others is a useful metaphor in understanding the process of rehabilitation or recovery in treatment programs.     

ABH and Lewis antigens in the tracheal glands. I. Lewis-positive individuals

Antigens A, B, H, Lea, and Leb were demonstrated in the tracheal glands of 15 Lewis-positive secretors and 15 nonsecretors by the indirect immunoperoxidase technique. The detection of group-specific ABH antigens in mucous epithelium and intraductal secretory fluid was dependent on the secretor character. Whereas determination of secretor character was sometimes unreliable with anti-A and anti-B, the findings obtained by additional labeling with UEA1 were consistently correct. The secretors showed minimal gland labeling with anti-Lea and intensive labeling with anti-Leb; the nonsecretors, intensive Lea labeling and weaker or absent Leb labeling. Consequently, the determination of secretor character by ABH labeling could be verified by the behavior of the Lewis antigens. Since both morphologic structures and epithelial antigens are highly resistant to putrefaction, ABO and secretor character can also be diagnosed in badly decomposed tracheal wall specimens.     

Progestational drug products for human use; requirements for labeling directed to the patient. Food and Drug Administration, HHS. Final rule

The Food and Drug Administration (FDA) is revoking its regulation requiring patient labeling for progestational drug products. Patient labeling had been required to inform patients of an increased risk of birth defects reported to be associated with the use of these drugs during the first 4 months of pregnancy. FDA concluded that, based on a review of the scientific data, such labeling for all progestogens is not warranted. In addition, the diversity of drugs that can be described as progestational and the diversity of conditions these drugs may be used to treat make it inappropriate to consider these drugs a single class for labeling purposes. This action is intended to provide consumers with more appropriate labeling for certain drug products.     

Revisions to labeling requirements for blood and blood components, including source plasma. Final rule

The Food and Drug Administration (FDA) is revising the labeling requirements for blood and blood components intended for use in transfusion or for further manufacture by combining, simplifying, and updating specific regulations applicable to labeling and circulars of information. These requirements will facilitate the use of a labeling system using machine-readable information that would be acceptable as a replacement for the ``ABC Codabar' system for the labeling of blood and blood components. FDA is taking this action as a part of its efforts to comprehensively review and, as necessary, revise its regulations, policies, guidances, and procedures related to the regulation of blood and blood components. This final rule is intended to help ensure the continued safety of the blood supply and facilitate consistency in labeling.     

CONFLICTS AND HARMONIZATION ON GM FOOD LABELING IN INTERNATIONAL LAW

This article analyzes the conflicts of international law on genetically modified (GM) food labeling and explains possible methods to harmonize these conflicts. One way is to interpret the treaties of the World Trade Organization (WTO), Biodiversity Convention, and the International Court of Justice (ICJ); the other way is to enhance cooperation among international institutions and treaties, such as WTO, Biodiversity Convention, Codex Alimentarius Commission (CAC), International Law Commission (ILC), and the United Nations Environment Programme (UNEP). These methods cannot form an international standard on GM food labeling accepted by most countries. The difficulties with this issue concerned illustrate that GM food labeling shows off conflicts between trade law and environmental law, which lead to legal chaos that is faced with uncertainty of technology, fragmentation of international law and diversity of domestic law, and complexity of national interests on environmental labeling and process labeling.     

Natural rubber-containing medical devices; user labeling--FDA. Final rule

The Food and Drug Administration (FDA) is issuing a final rule requiring labeling statements on medical devices, including device packaging containing natural rubber that contacts humans. The rule requires labeling of medical devices containing natural rubber latex that contacts humans to state: "Caution: This Product Contains Natural Rubber Latex Which May Cause Allergic Reactions."; labeling of medical devices containing dry natural rubber that contacts humans to state: "This Product Contains Dry Natural Rubber."; labeling of medical devices containing natural rubber latex in their packaging that contacts humans to state: "Caution: The Packaging of This Product Contains Natural Rubber Latex Which May Cause Allergic Reactions."; labeling of medical devices containing dry natural rubber in their packaging that contacts humans to state: "The Packaging of This Product Contains Dry Natural Rubber."; and that the claim of hypoallergenicity be removed from the labeling of medical devices that contain natural rubber. These requirements are being established in response to numerous reports of severe allergic reactions and deaths related to a wide range of medical devices containing natural rubber.     

Official offense status and self-esteem among Chinese youths

The present study assessed an important hypothesis derived from the labeling perspective that official labeling of delinquency reduces self-esteem of the labeled individual. Although evidence for the hypothesis is rare in the U.S. research, it has been proposed that the relationship between official labeling and self-esteem may vary across different social and cultural contexts. China has a distinctive social and cultural setting and offers a unique opportunity to assess the hypothesis. It is argued that official labeling is likely to negatively affect self-esteem of the labeled youths in the social and cultural context of China. Using data collected from China, the study provided a preliminary test of the hypothesis. The findings support the hypothesis.